Details for New Drug Application (NDA): 210267
✉ Email this page to a colleague
The generic ingredient in TIZANIDINE HYDROCHLORIDE is tizanidine hydrochloride. There are eleven drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tizanidine hydrochloride profile page.
Summary for 210267
Tradename: | TIZANIDINE HYDROCHLORIDE |
Applicant: | Novast Labs |
Ingredient: | tizanidine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 210267
Mechanism of Action | Adrenergic alpha2-Agonists |
Suppliers and Packaging for NDA: 210267
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | CAPSULE;ORAL | 210267 | ANDA | Ingenus Pharmaceuticals, LLC | 50742-224 | 50742-224-15 | 150 CAPSULE in 1 BOTTLE, PLASTIC (50742-224-15) |
TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | CAPSULE;ORAL | 210267 | ANDA | Ingenus Pharmaceuticals, LLC | 50742-225 | 50742-225-15 | 150 CAPSULE in 1 BOTTLE, PLASTIC (50742-225-15) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Mar 12, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Mar 12, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 6MG BASE | ||||
Approval Date: | Mar 12, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription